Perrigo Company plc Increase (Decrease) in Accrued Liabilities
Perrigo Company plc (PRGO) reported Increase (Decrease) in Accrued Liabilities of $30.60 million for the 3-month period ending 2024-03-30, per its 10-Q filed 2024-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-05-07
- Perrigo Company plc increase (decrease) in accrued liabilities for the quarter ending 2024-03-30 was $30.60M, a 282.50% increase year-over-year.
- Perrigo Company plc increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was -$6.60M.
- Perrigo Company plc increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $13.50M, a 181.25% increase year-over-year.
- Perrigo Company plc increase (decrease) in accrued liabilities for the quarter ending 2023-07-01 was -$8.30M.
- Perrigo Company plc increase (decrease) in accrued liabilities for fiscal 2023 was $6.60M, a 34.65% decline from fiscal 2022.
- Perrigo Company plc increase (decrease) in accrued liabilities for fiscal 2022 was $10.10M.
- Perrigo Company plc increase (decrease) in accrued liabilities for fiscal 2021 was -$21.40M.
- Perrigo Company plc increase (decrease) in accrued liabilities for fiscal 2020 was -$23.10M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-30 | $30.60M 10-Q · filed 2024-05-07 | $24.00M derived: sum of 2 quarters · filed 2024-05-07 | $37.50M derived: sum of 3 quarters · filed 2024-05-07 | $29.20M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2023-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.90M derived: sum of 2 quarters · filed 2024-02-27 | -$1.40M derived: sum of 3 quarters · filed 2024-02-27 | $6.60M 10-K · filed 2024-02-27 | ||||
| 2023-09-30 | $13.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.20M derived: sum of 2 quarters · filed 2023-11-07 | $13.20M 10-Q · filed 2023-11-07 | $4.30M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2023-07-01 | -$8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$300.00K 10-Q · filed 2023-08-08 | -$9.20M derived: sum of 3 quarters · filed 2024-05-07 | -$4.40M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2023-04-01 | $8.00M 10-Q · filed 2024-05-07 | -$900.00K derived: sum of 2 quarters · filed 2024-05-07 | $3.90M derived: sum of 3 quarters · filed 2024-05-07 | -$5.60M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$4.10M derived: sum of 2 quarters · filed 2024-02-27 | -$13.60M derived: sum of 3 quarters · filed 2024-02-27 | $10.10M 10-K · filed 2024-02-27 | ||||
| 2022-10-01 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$4.70M derived: sum of 2 quarters · filed 2023-11-07 | $19.00M 10-Q · filed 2023-11-07 | $3.40M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $14.20M 10-Q · filed 2023-08-08 | -$1.40M derived: sum of 3 quarters · filed 2024-02-27 | $24.90M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | $23.70M 10-Q · filed 2023-05-09 | $8.10M derived: sum of 2 quarters · filed 2024-02-27 | $34.40M derived: sum of 3 quarters · filed 2024-02-27 | -$6.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $10.70M derived: sum of 2 quarters · filed 2024-02-27 | -$29.90M derived: sum of 3 quarters · filed 2024-02-27 | -$21.40M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $26.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$14.30M derived: sum of 2 quarters · filed 2022-11-08 | -$5.80M 10-Q · filed 2022-11-08 | -$12.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | -$40.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$32.10M 10-Q · filed 2022-08-09 | -$39.20M derived: sum of 3 quarters · filed 2023-02-28 | -$47.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $8.50M 10-Q · filed 2022-05-11 | $1.40M derived: sum of 2 quarters · filed 2023-02-28 | -$6.70M derived: sum of 3 quarters · filed 2023-02-28 | -$25.70M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$15.20M derived: sum of 2 quarters · filed 2023-02-28 | -$34.20M derived: sum of 3 quarters · filed 2023-02-28 | -$23.10M 10-K · filed 2023-02-28 | ||||
| 2020-09-26 | -$8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$27.10M derived: sum of 2 quarters · filed 2021-11-12 | -$16.00M 10-Q · filed 2021-11-12 | -$14.40M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-27 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$7.90M 10-Q · filed 2021-08-11 | -$6.30M derived: sum of 3 quarters · filed 2022-03-01 | -$11.90M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-28 | $11.10M 10-Q · filed 2021-05-12 | $12.70M derived: sum of 2 quarters · filed 2022-03-01 | $7.10M derived: sum of 3 quarters · filed 2022-03-01 | -$8.30M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$4.00M derived: sum of 2 quarters · filed 2022-03-01 | -$19.40M derived: sum of 3 quarters · filed 2022-03-01 | -$23.20M 10-K · filed 2022-03-01 | ||||
| 2019-09-28 | -$5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$21.00M derived: sum of 2 quarters · filed 2020-11-05 | -$24.80M 10-Q · filed 2020-11-05 | -$14.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | -$15.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$19.20M 10-Q · filed 2020-08-05 | -$9.00M derived: sum of 3 quarters · filed 2021-03-01 | -$9.70M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | -$3.80M 10-Q · filed 2020-05-05 | $6.40M derived: sum of 2 quarters · filed 2021-03-01 | $5.70M derived: sum of 3 quarters · filed 2021-03-01 | -$700.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $9.50M derived: sum of 2 quarters · filed 2021-03-01 | $3.10M derived: sum of 3 quarters · filed 2021-03-01 | -$20.90M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$7.10M derived: sum of 2 quarters · filed 2019-11-06 | -$31.10M 10-Q · filed 2019-11-06 | -$60.10M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$30.40M 10-Q · filed 2019-08-08 | -$59.40M derived: sum of 3 quarters · filed 2020-02-27 | -$28.80M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$24.00M 10-Q · filed 2019-05-09 | -$53.00M derived: sum of 2 quarters · filed 2020-02-27 | -$22.40M derived: sum of 3 quarters · filed 2020-02-27 | -$74.10M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.60M derived: sum of 2 quarters · filed 2020-02-27 | -$50.10M derived: sum of 3 quarters · filed 2020-02-27 | -$47.80M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $30.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$21.10M derived: sum of 2 quarters · filed 2018-11-08 | -$18.80M 10-Q · filed 2018-11-08 | -$8.30M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | -$51.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$49.40M 10-Q · filed 2018-08-09 | -$38.90M derived: sum of 3 quarters · filed 2019-02-27 | -$75.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $2.30M 10-Q · filed 2018-05-08 | $12.80M derived: sum of 2 quarters · filed 2019-02-27 | -$23.30M derived: sum of 3 quarters · filed 2019-02-27 | -$64.40M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$25.60M derived: sum of 2 quarters · filed 2019-02-27 | -$66.70M derived: sum of 3 quarters · filed 2019-02-27 | -$79.50M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | -$36.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$77.20M derived: sum of 2 quarters · filed 2017-11-09 | -$90.00M 10-Q · filed 2017-11-09 | -$42.80M 10-Q · filed 2016-11-10 | -$43.40M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-07-02 | -$41.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$53.90M 10-Q · filed 2017-08-10 | -$9.80M 10-Q · filed 2016-08-10 | -$7.30M derived: sum of 3 quarters · filed 2018-03-01 | $54.20M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-04-02 | -$12.80M 10-Q · filed 2017-05-30 | -$3.40M 10-Q · filed 2016-05-16 | $33.80M derived: sum of 2 quarters · filed 2018-03-01 | $95.30M derived: sum of 3 quarters · filed 2018-03-01 | $88.50M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $46.60M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $108.10M 10-K · filed 2018-03-01 | $75.60M 10-KT · filed 2016-02-25 | $101.30M derived: sum of 3 quarters · filed 2018-03-01 | $98.80M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $61.50M 10-Q · filed 2015-11-02 | $54.70M derived: sum of 2 quarters · filed 2017-05-22 | $41.10M 10-Q/A · filed 2017-05-23 | $46.70M 10-Q · filed 2016-11-10 | $103.60M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2015-06-27 | -$6.80M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$9.30M 10-Q/A · filed 2017-05-22 | -$14.80M 10-Q · filed 2016-08-10 | $42.10M derived: sum of 3 quarters · filed 2017-05-22 | $42.80M 10-K · filed 2018-03-01 | $37.30M 10-K · filed 2015-08-13 | ||
| 2015-03-28 | -$2.50M 10-Q/A · filed 2017-05-22 | $48.90M derived: sum of 2 quarters · filed 2017-05-22 | $49.60M 10-Q · filed 2015-04-29 | $63.70M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-12-27 | $51.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $52.00M 10-Q · filed 2015-02-05 | $66.20M derived: sum of 3 quarters · filed 2017-05-22 | $73.00M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-09-27 | $600.00K 10-Q · filed 2015-11-02 | $14.80M derived: sum of 2 quarters · filed 2017-05-22 | $21.60M derived: sum of 3 quarters · filed 2017-05-22 | $2.40M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-06-28 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $21.00M derived: sum of 2 quarters · filed 2017-05-22 | $1.80M derived: sum of 3 quarters · filed 2017-05-22 | $23.00M 10-K · filed 2017-05-22 | ||||
| 2014-03-29 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | -$12.40M derived: sum of 2 quarters · filed 2015-04-29 | $8.80M 10-Q · filed 2015-04-29 | $7.10M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-28 | -$19.20M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $2.00M 10-Q · filed 2015-02-05 | $300.00K derived: sum of 3 quarters · filed 2016-02-25 | $17.50M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-28 | $21.20M 8-K · filed 2014-11-20 | $19.50M derived: sum of 2 quarters · filed 2016-02-25 | $36.70M derived: sum of 3 quarters · filed 2016-02-25 | |||||
| 2013-06-29 | -$1.70M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $15.50M derived: sum of 2 quarters · filed 2016-02-25 | $8.40M 10-KT · filed 2016-02-25 | |||||
| 2013-03-30 | $17.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $10.10M 10-Q · filed 2014-05-07 | ||||||
| 2012-12-29 | -$7.10M 10-Q · filed 2014-02-06 | |||||||
| 2012-06-30 | $4.20M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |